Skip to main content
SpringerLink
Log in

Prostigmin treatment of myasthenia gravis

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Conclusion

A case of myasthenia gravis is reported in which prostigmin has been used orally for a period of 11 months, enabling the patient to pursue her usual occupation.

Because of a coexistent pelvic infection sulfanilamide was tried but without benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Edgeworth, Harriet: A report of progress on the use of ephedrine in a case of myasthenia gravis. J. A. M. A., 94:1136, April 12, 1930.

    Google Scholar 

  2. Boothby, W. M.: Myasthenia gravis—a preliminary report on the effect of treatment with glycine. Proc. Staff Meet, Mayo Clinic, 7:557–562, September 22, 1932.

    Google Scholar 

  3. Remen, L.: Zur Pathogenese und Therapie der Myasthenia Gravis pseudoparalytica. Deutsch. Ztschr. f. Nervenh., 128:66–78, 1932.

    Google Scholar 

  4. Walker, M. B.: Treatment of myasthenia gravis with physostigmine. Lancet, 1:1200–1201. June 2, 1934.

    Google Scholar 

  5. Nevin, S.: Study of muscle chemistry in myasthenia gravis. Brain, 57:239–254, October, 1934.

    Google Scholar 

  6. Pritchard, E. A. B., and Walker, M. B.: The effect of prostigmin on the symptoms and on the myogram in myasthenia gravis. J. Physiol., 84:35–36, 1935.

    Google Scholar 

  7. Walker, Mary: Case showing effect of prostigmin on myasthenia gravis. Proc. Roy. Soc. Med., 28:759–761, April, 1935.

    Google Scholar 

  8. Everts, W. H.: The treatment of myasthenia gravis by the oral administration of prostigmin. Bull. Neurol. Inst., New York, 4:523–530, December, 1935.

    Google Scholar 

  9. Goodman, Louis, S., and Bruckner, William J.: The therapeutics of prostigmin. J. A. M. A., 108:965–968, March 20, 1937.

    Google Scholar 

  10. Viets, Henry R., Mitchell, Roger S., and Schwab, Robert S.: Prostigmin in myasthenia gravis. J. A. M. A., 109:1956, December 11, 1937.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 293 Genesee Street, Utica, N. Y.

    F. M. Miller Jr. M. D. & Harold H. Dodds M. D.

  2. Marcy State Hospital, Marcy, N. Y.

    F. M. Miller Jr. M. D. & Harold H. Dodds M. D.

Authors
  1. F. M. Miller Jr. M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harold H. Dodds M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Presented before the Utica and Syracuse Academies of Medicine, September 22, 1938.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, F.M., Dodds, H.H. Prostigmin treatment of myasthenia gravis. Psych Quar 13, 90–95 (1939). https://doi.org/10.1007/BF01579226

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01579226

Keywords

Search

Navigation